Egan AG, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, and Rosebraugh C
There isnt strong proof that GLP-1 medicines directly cause DME, but its something doctors keep an eye on
Recent FDA approvals have expanded the indication for semaglutide to include the reduction of major adverse cardiovascular events (MACE), such as heart attack, stroke, and cardiovascular death, in adults with established cardiovascular disease and obesity
TB-500 upregulates VEGF and actin-binding proteins to initiate new capillary formation, while BPC-157 stabilises and organises the resulting vascular networks through its endothelial repair and VEGFR2 signalling activity